Calendula

At ORY®, we believe you should know what’s in your products and why. This page lists the published research behind what we say about calendula flower and calendula-infused oil. Each section starts with our claim, then tells you how well the research supports it, then lists the sources so you can read them yourself.

Please note: Some studies on this page tested calendula for wounds or for skin reactions during radiation therapy, which are medical uses. We share them for transparency. ORY® calendula products are cosmetics and are not intended to treat any condition.

How to read this page

Supported — backed by peer-reviewed research or official safety reviews.

Supported, with caveats — the research points this way, but mostly from laboratory or animal studies, or at different strengths than ORY® uses.

Limited evidence — little or no published research yet. We say so openly.

1. General Description and Role

Claim: Calendula (Calendula officinalis, pot marigold) is a golden-orange flower in the daisy family. ORY® uses the dried petals and calendula-infused oil. They help skin, lips, and scalp feel soothed, soft, and comfortable.

Verification: Supported. The Cosmetic Ingredient Review (CIR) Expert Panel found calendula-derived ingredients, including the flower and flower oil, safe in cosmetics at reported use. Reviews describe anti-inflammatory and antioxidant compounds in the flower.

Citations:

    • Andersen, F. A., Bergfeld, W. F., Belsito, D. V., et al. (2010). Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. International Journal of Toxicology, 29(6 Suppl), 221S–243S. https://doi.org/10.1177/1091581810384883
      • What it shows: CIR safety assessment of calendula ingredients.
    • Muley, B. P., Khadabadi, S. S., & Banarase, N. B. (2009). Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): A review. Tropical Journal of Pharmaceutical Research, 8(5), 455–465. https://doi.org/10.4314/tjpr.v8i5.48090
      • What it shows: Review of calendula’s compounds and activity.
2. Composition and Production

Claim: Steeping dried petals in oil carries over oil-soluble compounds such as faradiol esters (triterpenes) and carotenoids. Water-soluble flavonoids stay mostly in the plant and are better captured by calendula extract.

Verification: Supported. Calendula chemistry is well documented. ORY® infused oils are made by steeping dried plant material in a carrier oil. The carrier oil makes up most of the finished product, so its own properties matter as much as the botanical’s — including allergy: nut-derived carrier oils such as sweet almond oil may not suit people with tree-nut allergies.

Citations:

    • Muley, B. P., Khadabadi, S. S., & Banarase, N. B. (2009). Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): A review. Tropical Journal of Pharmaceutical Research, 8(5), 455–465. https://doi.org/10.4314/tjpr.v8i5.48090
      • What it shows: Describes calendula’s compounds.
3. Skin Type Suitability

Claim: Calendula-infused oil suits dry, normal, sensitive, and mature skin. Oily skin should choose a light carrier oil or calendula extract.

Verification: Supported, with caveats. CIR reported calendula as non-sensitizing in clinical tests, but calendula is in the daisy family, and allergy has been reported in people sensitive to related plants.

Citations:

    • Andersen, F. A., Bergfeld, W. F., Belsito, D. V., et al. (2010). Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. International Journal of Toxicology, 29(6 Suppl), 221S–243S. https://doi.org/10.1177/1091581810384883
      • What it shows: Safety data.
    • Paulsen, E. (2002). Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis, 47(4), 189–198. https://doi.org/10.1034/j.1600-0536.2002.470401.x
      • What it shows: Review of allergy to daisy-family plants in cosmetics.
4. Hair and Scalp Suitability

Claim: In haircare, calendula-infused oil helps the scalp feel comfortable and helps hair feel soft.

Verification: Limited evidence. We found no clinical studies of calendula on the scalp or hair. ORY® haircare products are not intended to treat dandruff or scalp conditions.

Citations:

5. Benefits

Claim: Calendula-infused oil helps dry, rough skin feel soft, soothed, and comfortable.

Verification: Supported, with caveats. Emollient benefits come mostly from the carrier oil. Wound studies in animals and a systematic review support calendula for wound healing, and a large trial found calendula cream reduced skin reactions during radiation therapy, although a later trial found no difference from a plain cream. These are medical uses; ORY® does not make wound, burn, eczema, diaper-rash, or radiation claims.

Citations:

    • Preethi, K. C., & Kuttan, R. (2009). Wound healing activity of flower extract of Calendula officinalis. Journal of Basic and Clinical Physiology and Pharmacology, 20(1), 73–80. https://doi.org/10.1515/JBCPP.2009.20.1.73
      • What it shows: Rat wound study.
    • Givol, O., Kornhaber, R., Visentin, D., Cleary, M., Haik, J., & Harats, M. (2019). A systematic review of Calendula officinalis extract for wound healing. Wound Repair and Regeneration, 27(5), 548–561. https://doi.org/10.1111/wrr.12737
      • What it shows: Systematic review of wound healing.
    • Pommier, P., Gomez, F., Sunyach, M. P., D’Hombres, A., Carrie, C., & Montbarbon, X. (2004). Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. Journal of Clinical Oncology, 22(8), 1447–1453. https://doi.org/10.1200/JCO.2004.07.063
      • What it shows: Radiation dermatitis trial (a medical use).
    • Sharp, L., Finnilä, K., Johansson, H., Abrahamsson, M., Hatschek, T., & Bergenmar, M. (2013). No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions – Results from a randomised blinded trial. European Journal of Oncology Nursing, 17(4), 429–435. https://doi.org/10.1016/j.ejon.2012.11.003
      • What it shows: Later trial with no difference from a plain cream.
6. Use Across ORY® Product Lines

Claim: Calendula petals and infused oil are used in all four ORY® product lines.

Verification: Supported, with caveats. Calendula petals are added for their skin benefits and appearance in the bar, not as a colorant. Calendula is not an FDA-approved color additive for cosmetics.

Product lineTypical levelHow ORY® uses it
Skincare10–100% infused oilFace and body oils, balms, cuticle oils, massage oils, and cleansing balms.
Haircare5–20% infused oilScalp oils, hair oils, and hot-oil treatments.
Handmade Soap10–30% of oils as infusion; 1–2 tbsp petals per lbInfused oil in the recipe; petals in and on the bar.
Cosmetics5–20% infused oilLip balms and cuticle treatments.

Citations:

7. Pros

Claim: A gentle, traditional flower with a CIR safety conclusion.

Verification: Supported. Well tolerated by most people.

Citations:

    • Andersen, F. A., Bergfeld, W. F., Belsito, D. V., et al. (2010). Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. International Journal of Toxicology, 29(6 Suppl), 221S–243S. https://doi.org/10.1177/1091581810384883
      • What it shows: Safety conclusion.
8. Cons

Claim: Calendula can cause allergy in daisy-sensitive people, infusion strength varies, and infused oils can go rancid.

Verification: Supported. We list these limits so you have the full picture:

    • Allergy. Daisy-family allergy is possible.
    • Variable strength. Depends on petal quality, ratio, and steeping time.
    • Rancidity. Infused oils last about 6–12 months.
    • Medical studies. The strongest evidence is for wounds and radiation reactions, which ORY® cannot claim.

Citations:

    • Paulsen, E. (2002). Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis, 47(4), 189–198. https://doi.org/10.1034/j.1600-0536.2002.470401.x
      • What it shows: Allergy.
    • Sharp, L., Finnilä, K., Johansson, H., Abrahamsson, M., Hatschek, T., & Bergenmar, M. (2013). No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions – Results from a randomised blinded trial. European Journal of Oncology Nursing, 17(4), 429–435. https://doi.org/10.1016/j.ejon.2012.11.003
      • What it shows: Mixed clinical results.
9. Safety Notes

Claim: Patch test before use; for external use only.

Verification: Supported. Follow these precautions:

    • Patch test any new product on a small area for 24–48 hours before full use.
    • If you are allergic to ragweed, chamomile, daisies, or other plants in the daisy (Asteraceae) family, patch test carefully or avoid this product.
    • If you have a tree-nut allergy, check the carrier oil before use.
    • Store infused oils away from heat and light, and discard them if they smell rancid.
    • Stop use if redness, burning, itching, or rash occurs, and talk to a healthcare provider.
    • For external use only. Avoid the eyes. Do not use on broken or seriously damaged skin.
    • If you are pregnant, nursing, have a medical condition, or are buying for a child, ask a healthcare provider before use.

Citations:

10. Product-line notes
    • ORY® Skincare: For external use only. Not for deep or puncture wounds, animal bites, or serious burns.
    • ORY® Haircare: Designed for scalp comfort and the look and feel of hair. Not intended to treat dandruff or scalp conditions, or to promote hair growth or prevent hair loss. If you notice sudden shedding or a persistent itchy, flaking scalp, see a dermatologist.
    • ORY® Handmade Soap: Handmade soap is naturally alkaline, and each bar may vary slightly in color, scent, and texture. Not intended to treat eczema or any skin condition.
    • ORY® Cosmetics: Lip products are not intended to treat or protect chapped or cracked lips. Do not share applicators, and replace any product that changes color, smell, or texture.
11. References

Peer-reviewed research

    • Andersen, F. A., Bergfeld, W. F., Belsito, D. V., et al. (2010). Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. International Journal of Toxicology, 29(6 Suppl), 221S–243S. https://doi.org/10.1177/1091581810384883
    • Givol, O., Kornhaber, R., Visentin, D., Cleary, M., Haik, J., & Harats, M. (2019). A systematic review of Calendula officinalis extract for wound healing. Wound Repair and Regeneration, 27(5), 548–561. https://doi.org/10.1111/wrr.12737
    • Muley, B. P., Khadabadi, S. S., & Banarase, N. B. (2009). Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): A review. Tropical Journal of Pharmaceutical Research, 8(5), 455–465. https://doi.org/10.4314/tjpr.v8i5.48090
    • Paulsen, E. (2002). Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis, 47(4), 189–198. https://doi.org/10.1034/j.1600-0536.2002.470401.x
    • Pommier, P., Gomez, F., Sunyach, M. P., D’Hombres, A., Carrie, C., & Montbarbon, X. (2004). Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. Journal of Clinical Oncology, 22(8), 1447–1453. https://doi.org/10.1200/JCO.2004.07.063
    • Preethi, K. C., & Kuttan, R. (2009). Wound healing activity of flower extract of Calendula officinalis. Journal of Basic and Clinical Physiology and Pharmacology, 20(1), 73–80. https://doi.org/10.1515/JBCPP.2009.20.1.73
    • Sharp, L., Finnilä, K., Johansson, H., Abrahamsson, M., Hatschek, T., & Bergenmar, M. (2013). No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions – Results from a randomised blinded trial. European Journal of Oncology Nursing, 17(4), 429–435. https://doi.org/10.1016/j.ejon.2012.11.003

Government and regulatory sources

Leave a Comment

Your email address will not be published.

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare